Basaglar KwikPen (Insulin Glargine)

Additional information

Basaglar KwikPen (Insulin Glargine)'s dosage depends on the condition (usual range: 0.1 units/kg/day - 1 units/kg/day). However, your doctor or pharmacist may have suggested a different schedule that is more appropriate for you. Your required dose of insulin depends on how much natural insulin your pancreas is producing and how well your body is able to use the insulin. It is only injected subcutaneously (under the skin), not intravenously (into the vein) or intramuscularly (into the muscle). You may take Basaglar at anytime during the day, but you must take it at the same time every day. Make sure the insulin is at room temperature when opening to minimize local irritation at the injection site. Wash your hands. Carefully follow the injection pen directions for loading the cartridge into the injection pen. Do not shake or rotate the KwikPen before use. Remove the protective cap. Follow the injection pen directions for attaching and changing the needle. Inject the pen. Slowly count to 5 before removing the needle from the injection site and gently apply pressure for several seconds. Do not rub the area. Important: Follow the instructions on the label. Do not use more of this product, or more often, than prescribed. If you forget a dose, contact your pharmacist.
 
WARNING: Rotate your injection sites (stomach, thigh, buttock, or upper arm) you choose for each dose. Hyperglycemia (high blood sugar) or hypoglycemia (low blood sugar) may result from changes in meal pattern (e.g., type of foods eaten, timing of meals), changes in the level of physical activity, increased work or exercise without eating, or changes to coadministered medications. Use of long-acting insulin preparations such as Basaglar may delay recovery from hypoglycemia. Glucose monitoring is recommended for all patients with diabetes. Any change of insulin regimen should be made cautiously and only under medical supervision.
 
In addition to its desired action, Basaglar KwikPen (Insulin Glargine) may cause some side effects, notably:
It may cause low blood sugar (hypoglycemia), fatigue, tingling of hands or feet, or blurred vision.
It may cause high blood sugar (hyperglycemia) if the dose is too little. 
It may cause a little depression in the skin (lipoatrophy), skin thickening (lipohypertrophy), skin lumps (localized cutaneous amyloidosis). 
It may cause redness, swelling, or itching at injection site, or diarrhea. 
 
Contraindications: Hypersensitivity to insulin glargine or any component of the formulation. Do not use during episodes of hypoglycemia (low blood sugar). 
 
Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women. If you're planning a pregnancy or become pregnant or breastfeeding, contact your family doctor. 
 
A treatment with Basaglar KwikPen (Insulin Glargine) requires regular monitoring by a doctor. Be sure to see your doctor for all regularly scheduled appointments.Basaglar KwikPen (Insulin Glargine)